PharVision Advisers
INN icon

PharVision Advisers’s Summit Hotel Properties INN Stock Holding History

PharVision Advisers’s Portfolio INN Stock Details INN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		– Sell
-16,336
Closed -$115K – 48
2026
Q2 		$115K Buy
+16,336
New +$90.2K 2.16% 10
2025
Q4 		– Sell
-39,995
Closed -$220K – 839
2025
Q3 		$220K Buy
+39,995
New +$218K 0.12% 430

Other funds holding INN

Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return
GWI
Grace & White Inc Ny, New York $610M AUM 24.71% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $348B AUM 26.9% 1-Year Est. Return
Russell Investments Group
Russell Investments Group London, United Kingdom $114B AUM 33.83% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $54.1B AUM 39.29% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $195B AUM 21.17% 1-Year Est. Return
US Bancorp
US Bancorp Minneapolis, Minnesota $92B AUM 22.91% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $500B AUM 36.84% 1-Year Est. Return

PharVision Advisers's INN Position: Q3 2026 in Review

PharVision Advisers sold out of Summit Hotel Properties (INN) in Q3 2026, closing a stake of 16,336 shares — an estimated $115K sold.

PharVision Advisers first reported a position in INN in Q3 2025 and held it in 2 quarters. The position peaked at $220K in Q3 2025. 73 funds tracked by Wall St. Rank hold INN as of Q3 2026.

  • PharVision Advisers reported no remaining Summit Hotel Properties position as of Q3 2026 after selling out during the quarter.
  • PharVision Advisers sold 16,336 Summit Hotel Properties shares in Q3 2026, an estimated $115K.
  • PharVision Advisers first reported a position in Summit Hotel Properties in Q3 2025 and held it in 2 quarters.
  • PharVision Advisers's Summit Hotel Properties position peaked at $220K in Q3 2025.
  • 73 funds tracked by Wall St. Rank held Summit Hotel Properties as of Q3 2026.

Based on PharVision Advisers's 13F filing for Q3 2026, filed 29 Oct 2026.